| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.076 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |